|
JAPAN
For more information, please contact:
- Ivana Ballian | E-mail Address: iballian@pharmaforceintl.com Send E-mail
- Joyce Wedemeyer | E-mail Address: Joyce.Wedemeyer@pharmaforce.biz Send E-mail
SUBSCRIPTIONS
A powerful web-based program that allows clients to access up-to-date
information on the leading pharmaceutical sales forces in Japan
AVAILABLE SYNDICATED STUDIES
This benchmarking program offers unparalleled in-depth analysis of the
sales and marketing activities supporting key oncology brands in Japan
The report profiles existing players as well as new entrants in Hemophilia
therapeutic area in Japan. Both Hemophilia A and Hemophilia B products will be
profiled in the report along with a focus on smaller, more complex commercial
teams
-
Select Biosimilars Sales and Marketing Organizations
[2017] [2016]
This report offers market intelligence and benchmarking in the emerging
biosimilar therapeutic area in Japan
This report benchmarks commercial operations for leading companies competing in the
dynamic immunology specialty market in Japan
This benchmarking program describes in detail each leading pharmaceutical company’s strategy for leveraging medical liaisons and similar personnel in Japan
-
Multiple Sclerosis Sales and Marketing Franchises
[2017] [2016]
This comprehensive study includes side-by-side comparisons of commercial operations and marketing spend for the top multiple sclerosis franchises in Japan
-
Diabetes: Commercial Operations Approaches [2018]
This report benchmarks commercial operations for leading companies competing in the dynamic diabetes specialty market in Japan
ABSTRACTS
This abstract will provide the competitive
knowledge for your cardiovascular teams to analyze the deployment strategies
of select market leaders in Japan\
STILL DIDN'T FIND WHAT YOU ARE LOOKING FOR?
|